Mucormycoses are invasive infections by species and other Mucorales. Over 10 months, four solid organ transplant (SOT) recipients at our centre developed mucormycosis due to (=2), (=1) or (=1), at a median 31.5 days (range: 13-34) post-admission. We performed whole genome sequencing (WGS) on 72 Mucorales isolates (45 . , 19 . , six . , two species) from these patients, from five patients with community-acquired mucormycosis, and from hospital and regional environments. Isolates were compared by core protein phylogeny and global genomic features, including genome size, guanine-cytosine percentages, shared protein families and paralogue expansions. Patient isolates fell into six core phylogenetic lineages (clades). Phylogenetic and genomic similarities of isolates recovered 7 months apart from two SOT recipients in adjoining hospitals suggested a potential common source exposure. However, isolates from other patients and environmental sites had unique genomes. Many isolates that were indistinguishable by core phylogeny were distinct by one or more global genomic comparisons. Certain clades were recovered throughout the study period, whereas others were found at particular time points. In conclusion, mucormycosis cases could not be genetically linked to a definitive environmental source. Comprehensive genomic analyses eliminated false associations between Mucorales isolates that would have been assigned using core phylogenetic or less extensive genomic comparisons. The genomic diversity of Mucorales mandates that multiple isolates from individual patients and environmental sites undergo WGS during epidemiological investigations. However, exhaustive surveillance of fungal populations in a hospital and surrounding community is probably infeasible.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116672PMC
http://dx.doi.org/10.1099/mgen.0.000473DOI Listing

Publication Analysis

Top Keywords

mucorales isolates
12
isolates
9
mucormycosis cases
8
solid organ
8
organ transplant
8
sot recipients
8
global genomic
8
core phylogenetic
8
patients environmental
8
environmental sites
8

Similar Publications

Background: Mucormycosis, is a rare yet potentially life-threatening fungal infection common in immunocompromised patients. Despite optimal care, mucormycosis in haemato-oncological patients often results in poor outcomes. This case series details the presentations and unique challenges faced during the management of patients with acute myeloid leukemia who developed rhino-cerebral mucormycosis.

View Article and Find Full Text PDF

New from opposite ends of the world.

Stud Mycol

December 2024

Environmental Microbiology Laboratory, Department of Agricultural Biological Chemistry, College of Agriculture & Life Sciences, Chonnam National University, Gwangju 61186, South Korea.

The is a group of ancient fungi with global distribution. In the current study we accessed mucoralean fungi isolated from two countries on opposite sides of the Earth and in different hemispheres: South Korea and Brazil. isolates were obtained from freshwater, soil, invertebrates, and fruit seeds and identified using phenotypic techniques combined with the DNA sequence data.

View Article and Find Full Text PDF

Introduction: Mucormycosis is an acute onset, invasive, fungal infection, characterized by organ involvement, and caused by Mucor, Rhizopus, or Absidia. Our aim was to present a case of mucormycotic infection and emphasize its importance in a diabetic immunosuppressed patient with acute myeloid leukemia (AML).

Case Presentation: A 68-year-old hypertensive and diabetic male patient with a diagnosis of AML developed respiratory failure and exhibited diffuse bilateral consolidation in high-resolution computed tomography (HRCT).

View Article and Find Full Text PDF

is distributed worldwide and primarily isolated from soil, feces, and decaying plants. The genus was initially classified into Absidiaceae and then Mucoraceae, and currently belongs to Cunninghamellaceae and is further divided into s.s.

View Article and Find Full Text PDF
Article Synopsis
  • COVID-19 patients are at a higher risk for fungal infections, prompting a study to identify fungal pathogens in both COVID positive and negative patients, as well as assess their antifungal resistance and biofilm formation abilities.
  • The study found a 6.70% prevalence of fungal pathogens in COVID-positive cases and 22.77% in negative cases, with Candida albicans being the most common pathogen identified.
  • Results indicated that most Candida species were susceptible to miconazole but resistant to ketoconazole, highlighting the need for increased awareness and antifungal susceptibility testing in clinical settings.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!